Bank Of America Corp Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$171.37 - $283.23 $1.68 Million - $2.78 Million
-9,800 Reduced 98.0%
200 $53,000
Q4 2023

Feb 14, 2024
SELL
$120.4 - $237.13 $2.41 Million - $4.74 Million
-20,000 Reduced 66.67%
10,000 $2.31 Million
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $6.12 Million - $9.36 Million
30,000 New
30,000 $6.93 Million

Others Institutions Holding MDGL

# of Institutions
294
Shares Held
21.8M
Call Options Held
757K
Put Options Held
370K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.78B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email